In 2023, Dr. Erkin Çınar ranked first in Türkiye in the HEM-TUYEK National Hematology Board Examination and, in the same year, successfully completed the European Hematology Association (EHA) examination, earning the EHA Exam Certificate. In 2025, he completed the Turkish Society of Hematology (THD) Master Class in Stem Cell Transplantation and Cellular Therapies, finishing first in the program. In 2026, he was elected a member of the EHA Specialized Working Group on Immune Therapies for Hematologic Disorders and took on the role of founding secretary of the THD Scientific Subcommittee on Artificial Intelligence.
His main areas of interest are acute leukemias, hematopoietic stem cell transplantation and other cellular therapies, targeted therapies, personalized medicine, and artificial intelligence in hematology. He has published more than 30 scientific articles in national and international peer-reviewed journals.
